UBS Group’s iPath Return on Disability ETN RODI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1
Closed 10844
2021
Q2
$0 Hold
1
﹤0.01% 10430
2021
Q1
$0 Hold
1
﹤0.01% 9974
2020
Q4
$0 Hold
1
﹤0.01% 9207
2020
Q3
$0 Hold
1
﹤0.01% 8860
2020
Q2
$0 Hold
1
﹤0.01% 8777
2020
Q1
$0 Hold
1
﹤0.01% 8908
2019
Q4
$0 Hold
1
﹤0.01% 8819
2019
Q3
$0 Hold
1
﹤0.01% 8618
2019
Q2
$0 Hold
1
﹤0.01% 8526
2019
Q1
$0 Hold
1
﹤0.01% 8642
2018
Q4
$0 Hold
1
﹤0.01% 8717
2018
Q3
$0 Hold
1
﹤0.01% 8631
2018
Q2
$0 Hold
1
﹤0.01% 8643
2018
Q1
$0 Hold
1
﹤0.01% 8581
2017
Q4
$0 Hold
1
﹤0.01% 8476
2017
Q3
$0 Buy
+1
New +$68 ﹤0.01% 8399
2016
Q4
Sell
-3
Closed 8451
2016
Q3
$0 Hold
3
﹤0.01% 8373
2016
Q2
$0 Buy
+3
New +$164 ﹤0.01% 8396
2016
Q1
Sell
-2
Closed 8853
2015
Q4
$0 Buy
+2
New +$109 ﹤0.01% 8983

Other funds holding RODI

UBS Group's RODI Position: Q3 2021 in Review

UBS Group sold out of iPath Return on Disability ETN (RODI) in Q3 2021, closing a stake of 1 share.

UBS Group first reported a position in RODI in Q4 2015 and held it in 19 quarters. The position peaked at $0 in Q2 2021. 2 funds tracked by Wall St. Rank hold RODI as of Q3 2021.

  • UBS Group reported no remaining iPath Return on Disability ETN position as of Q3 2021 after selling out during the quarter.
  • UBS Group sold 1 iPath Return on Disability ETN share in Q3 2021.
  • UBS Group first reported a position in iPath Return on Disability ETN in Q4 2015 and held it in 19 quarters.
  • UBS Group's iPath Return on Disability ETN position peaked at $0 in Q2 2021.
  • 2 funds tracked by Wall St. Rank held iPath Return on Disability ETN as of Q3 2021.

Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.